Abstract
Ochronosis is a rare autosomal-recessive disease, characterized by increased homogentisic acid (HGA) and substrates due to deficiency of HGA oxidase. The most common clinical presentations are homogentisic aciduria, blue-black pigment accumulation in collagen tissues, large joint arthropathies and degenerative disk diseases. However, the disease may exert very large spectrum with various system involvements. In this article, a patient who was admitted by progressed musculoskeletal system pains and diagnosed as ochronosis, especially with emerging cardiovascular involvement, was presented.
References
La Du BN (1983) Alcaptonuria in the metabolic basis of inherited disease. In: Stanbury JB, Wyngaardeb JB, Frederickson DS (eds), 3rd edn. New York, McGraw-Hill, pp 308–325
Ptacin M, Sebastian J, Bamrah VS (1985) Ochronotic cardiovascular disease. Clin Cardiol 8:441–445
Kenny D, Ptacin MJ, Bamrah VJ, Almagro U (1990) Cardiovascular ochronosis: a case report and review of the medical literature. Cardiology 77:477–483
Kragel AH, Lapa JA, Roberts WC (1990) Cardiovascular findings in alkaptonuric ochronosis. Am Heart J 120:1460–1463
Cercek M, Proksej K, Kozelj M (2002) Aortik valve stenosis in alkaptonuric ochronosis. J Heart Valve Dis 11(3):386–388
Kovacevic M, Simic O, Medved I, Lucin K, Padovan M (2006) Ochronosis of the aortic valve and aorta. J Heart Valve Dis 15(5):730–732
Butany JW, Naseemuddin A, Moshkowitz Y, Nair V (2006) Ochronosis and aortic valve stenosis. J Card Surg 21(2):182–184
Fisher AA, Davis MW (2004) Alkaptonuric ochronosis with aortic valve and joint replacements and femoral fracture: a case report and literature review. Clin Med Res 2(4):209–215
Goodfellow RJ, Schwartz J, Leya F (2005) BlackAorta: a rare finding at aortic valve replacement. J Invasive Cardiol 17(3):165–167
Kim YI, Daenen W (1992) Aortic valve replacement in cardiac ochronosis. Eur J Cardiothorac Surg 6(11):625–626
Levine HD, Parisi AF, Holdsworth DE, Cohn LH (1978) Aortic valve replacement for ochronosis of the aortic valve. Chest 74(4):466–467
Coodley EG, Greco AJ (1950) Clinical aspects of ochronosis with repot of a case. Am J Med 8:816
Erek E, Casselman FPA, Vanermen H (2004) Cardiac ochronosis. Tex Heart Inst J 31(4):445–447
Corra T, Zaccala M, Galante M (1995) Ochronotic arthropathy:rapid destructive hip osteoarthritis associated with metabolic disease. Clin Rheumatol 14:474–477
Mannoni A, Selvi E, Lorenzini S, Giorgi M, Airo P, Cammelli D, Andreotti L, Marcolongo R, Porfirio B (2004) Alkaptonuria, ochronosis, and ochronotic arthropathy. Semin Arthritis Rheum 33(4):239–248
Sutor DJ, Wooley SE, Krizek V (1970) The composition of calculi from patients with alcaptonuria. Br J Urol 42(4):386–388
Goldsmith L (1987) Disorders of metabolism. In: Fitzpatrick T, Arthur E, Wolff K, Irwin F, Frank A (eds)Dermatology in general medicine, 3rd edn. McGraw-Hill Book, New York, pp 1642–1646
Gaines J, Pai JR (1987) Cardiovasculer ochronosis. Arch Pathol Lab Med 111:991–994
Gould L, Reddy CV, DePalma D, De Martino A, Kalish PE (1976) Cardiac manifestations of ochronosis. J Thorac Cardiovasc Surg 72(5):788–791
Ross R, Glomset JA (1976) The pathogenesis of atherosclerosis. N Engl J Med 295:369–377
Folkes LV, Brull D, Krywawych S, Hayward M, Hughes SE (2007) Aortic stenosis in cardiovascular ochronosis. J Clin Pathol 60(1):92–93
Sarkany RP, Breathnach SM, Seymour CA, Weismann K, Burns DA (2004) Metabolic, nutritional disorders. In: Burns T, Breathnach S, Cox N, Griffiths C (eds) Textbook of dermatology, vol 3, 7th edn. Blackwell Science, Oxford, pp 81–83
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bal, S., Turan, Y., Koçyiğit, H. et al. Ochronosis with cardiovascular involvement: a case report. Rheumatol Int 28, 479–482 (2008). https://doi.org/10.1007/s00296-007-0456-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-007-0456-9